Conditions: Diabetes Mellitus, Type II
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 172
Healthy volunteers: no

Brief summary:
This study is going to assess the safety and tolerability of PF-06291874 in adults with Type 2 Diabetes Mellitus as monotherapy, to evaluate the significance of overall glycemic control in these subjects.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None arm 5: None

Interventions: intervention 1: Placebo intervention 2: PF-06291874 intervention 3: PF-06291874 intervention 4: PF-06291874 intervention 5: PF-06291874
Intervention descriptions: intervention 1: Tablet, once daily for 28 days intervention 2: Tablet, 15 mg, once daily for 28 days intervention 3: Tablet, 35 mg, once daily for 28 days intervention 4: Tablet, 75 mg, once daily for 28 days intervention 5: Tablet, 150 mg, once daily for 28 days

Protocol document: